Fig. 8From: Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro studyDetection of DNA Damage (comet assay) for all three cell types. Line graph is used to present the results (mean and error bars 95% CI is shown for all three cell lines, (for each treatment time per cell type n = 15)Back to article page